Jeff Hassall — ASN Events
  1. Schedule
  2. Jeff Hassall

Jeffrey Hassall

Amgen Australia, NSW, Australia

  • This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:

Effects of up to 10 years of denosumab treatment on bone matrix mineralisation: Results from the FREEDOM Extension (#159)

12:30 PM
Jeff Hassall
Poster Viewing III (all posters)